This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Savannah State University. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Karla-Sue C Marriott
Introduction
Karla-Sue C Marriott is a notable inventor based in Savannah, Georgia. She has made significant contributions to the field of chemistry, particularly in the development of benzofuran compounds. Her work has implications for pharmaceutical applications, showcasing her innovative spirit and dedication to advancing science.
Latest Patents
Karla-Sue C Marriott holds a patent for benzofuran compounds, compositions, kits, and methods thereof. This patent describes a benzofuran-2-carboxamide moiety that may be N-arylated and/or N-alkylated. The resulting benzofuran compound serves as a sigma receptor ligand that binds to sigma-1 and sigma-2 receptors with relatively high affinity and selectivity. Notable examples of the compounds include 5,6-dimethoxy-3-methyl-N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamide, 3-methyl-N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamide, and 6-methoxy-3-methyl-N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamide. The composition may also include a pharmaceutically acceptable carrier, enhancing its potential for medical use.
Career Highlights
Karla-Sue C Marriott is affiliated with Savannah State University, where she contributes to research and education in her field. Her academic background and professional experience have equipped her with the knowledge and skills necessary to innovate in the realm of chemical compounds.
Collaborations
Due to space constraints, details regarding collaborations will not be included.
Conclusion
Karla-Sue C Marriott's work in developing benzofuran compounds exemplifies her commitment to innovation in chemistry. Her contributions have the potential to impact pharmaceutical research and development significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile